Shaw J P, Ferry D G, Pethica D, Brenner D, Tucker I G
School of Pharmacy, University of Otago, Dunedin, New Zealand.
Tob Control. 1998 Summer;7(2):161-7. doi: 10.1136/tc.7.2.161.
To assess nicotine patch use in smokers who purchased the product as a non-prescription medicine from pharmacies.
A questionnaire administered at the time of purchase.
Community pharmacies throughout New Zealand.
A total of 805 male and female purchasers of nicotine patches aged 18 through 87 years.
Patterns of usage including self-reported smoking history, previous quit-smoking attempts, previous and current use of transdermal nicotine and other products, side effects, and concomitant smoking.
Most respondents (74%) had attempted to quit smoking previously, many of whom (53%) had used a non-prescription nicotine replacement product. Approximately 60% of purchasers were first-time users. For those continuing a course of treatment, there was no evidence of use for longer than the manufacturer's recommendation (12 weeks). Twenty-eight per cent of respondents reported continuing smoking while using transdermal nicotine, although the number of cigarettes smoked was much less than in the reported smoking history. Side effects were reported by 24% of patch users in the current course, but there was no evidence of significant safety problems.
This survey provides preliminary data on the non-prescription usage of transdermal nicotine when purchased through pharmacies.
评估从药店购买非处方药尼古丁贴片的吸烟者的使用情况。
购买时进行问卷调查。
新西兰各地的社区药店。
共805名年龄在18至87岁之间购买尼古丁贴片的男性和女性。
使用模式，包括自我报告的吸烟史、既往戒烟尝试、既往和当前使用经皮尼古丁及其他产品的情况、副作用以及同时吸烟情况。
大多数受访者（74%）此前曾尝试戒烟，其中许多人（53%）曾使用过非处方尼古丁替代产品。约60%的购买者是首次使用者。对于那些继续进行疗程治疗的人，没有证据表明使用时间超过了制造商的建议（12周）。28%的受访者报告在使用经皮尼古丁时仍继续吸烟，不过吸烟量比报告的吸烟史中要少得多。当前疗程中有24%的贴片使用者报告有副作用，但没有证据表明存在重大安全问题。
这项调查提供了通过药店购买经皮尼古丁非处方使用情况的初步数据。
